Babylon Biosciences
San Francisco
About Babylon Biosciences
Babylon Biosciences is focused on discovering and developing small-molecule therapeutics to treat Alzheimer's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2024)
- Website: babylon.bio
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/babylon-biosciences-2229560 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.